Mark A Glickman's Net Worth

$1.9 Million

Estimate Recalculated Nov 1, 2024 04:52AM EST

Who is Mark A Glickman?

Mark A Glickman has an estimated net worth of $1.9 Million. This is based on reported shares across multiple companies, which include Esperion Therapeutics, Inc., Aralez Pharmaceuticals Inc., TherapeuticsMD, Inc., NeuroBo Pharmaceuticals, Inc., AUXILIUM PHARMACEUTICALS INC, POZEN INC /NC, and OSCIENT PHARMACEUTICALS CORP.

SEC CIK

Mark A Glickman's CIK is 0001441461

Past Insider Trading and Trends

2014 was Mark A Glickman's most active year for acquiring shares with 8 total transactions. Mark A Glickman's most active month to acquire stocks was the month of January. 2014 was Mark A Glickman's most active year for disposing of shares, totalling 8 transactions. Mark A Glickman's most active month to dispose stocks was the month of December. 2014 saw Mark A Glickman paying a total of $837,250.00 for 127,325 shares, this is the most they've acquired in one year. In 2014 Mark A Glickman cashed out on 91,780 shares for a total of $1,666,870.23, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Esperion Therapeutics, Inc. (ESPR) Snapshot price: $1.69

Chief Commercial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+29.63%
5.92K
—
—
25.93K
Jan 2
Form 3
—
0
—
—
0
No matching records found

Aralez Pharmaceuticals Inc. No price found

Chief Commercial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-2.24%
-5.72K
$1.70
-$9,732.50
250.19K
Scheduled
Mar 19
Form 4
+45.61%
80.16K
—
—
255.91K
May 11
Form 4
-5.79%
-10.80K
$3.34
-$36,082.02
175.75K
Jun 22
Form 4
+15.47%
25K
$3.68
$92,050.00
186.55K
May 16
Form 4
+39.27%
45.55K
—
—
161.55K
Mar 17
Form 4
+298.12%
86.86K
—
—
116K
Feb 12
Form 4
∞
29.14K
—
—
29.14K
Feb 5
No matching records found

TherapeuticsMD, Inc. (TXMD) Snapshot price: $1.9

Co-Chief Executive Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
1.29K
$4.92
-$2,165.46
1.29K
Dec 6
Form 4
—
0
—
—
0
Mar 31
Form 4
—
0
—
—
0
Mar 23
Form 4
—
0
—
—
0
Oct 15
Form 3
—
0
—
—
0
No matching records found

NeuroBo Pharmaceuticals, Inc. (NRBO) Snapshot price: $3.51

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+107.72%
5.05K
—
—
9.74K
Jun 7
Form 4
∞
37.5K
—
—
37.5K
Jul 27
Form 3
—
0
—
—
0
No matching records found

AUXILIUM PHARMACEUTICALS INC No price found

EVP - Sales and Marketing

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-27.91K
$36.53
-$1,019,588.83
0
Jan 29
Form 4
-20.51%
-7.20K
$26.86
-$753,084.96
27.91K
Nov 20
Form 4/A
+88.15%
25.7K
—
—
54.85K
Feb 7 - Feb 18
Form 4
+107.25%
18.17K
$28.30
-$19,923.20
35.11K
Feb 18
Form 4
-10.49%
-1.99K
$23.68
-$47,028.48
16.94K
Feb 7
Form 4
-2.01%
-388.00
$24.70
-$9,583.60
18.93K
Feb 3
Form 4
+642.35%
16.71K
$18.30
-$7,795.80
19.32K
Feb 7
Form 4
-13.27%
-398.00
$18.85
-$7,502.30
2.6K
Feb 3
Form 4
—
0
—
—
0
Jul 19
Form 4
∞
3K
—
—
3K
Feb 3
Form 3
—
0
—
—
0
No matching records found